uniQure (QURE) Stock Price, Quote, News & History | Benzinga

SPY773.03+0.16%QQQ726.80−0.16%BTC/USD82,133.73+0.00%DIA521.35+0.03%GLD382.87+0.04%TLT79.90−0.09%

uniQure NV (QURE) Stock Price, Quote, News & History

QURENASDAQ

Trade with Public

Trade with Public

$22.52

1.557.39%

Last update: Oct 16, 7:31 AM

$22.53

1.567.44%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$22.52

Volume / Avg.

8.07K / 2.01M

Day Range

$22.53 - $22.53

52 Wk Range

8.73 - 71.50

Market Cap

$1.45B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

16

Short Interest

12.73%

Days to Cover

1.94

Recent uniQure N.V. News

Hewlett Packard Enterprise, Capital Bancorp, FormFactor And Other Big Stocks Moving Higher On Wednesday

U.S. stocks rose as Nasdaq gained 100+ points; HPE jumped 5.1% on stronger networking guidance and a Vultr AI rack order.

Avi Kapoor

Crude Oil Down 1%; US Job Openings Fall In August

U.S. stocks fell as job openings declined; oil slid and gold rose. BKYI doubled, SSTI surged, while NIVF plunged 77% and QURE fell 37%.

Avi Kapoor

Why Is uniQure Stock Sinking on Tuesday?

uniQure announced long-term trial results for its Huntington's gene therapy, showing slowed disease progression at 36 and 48 months.

Vandana Singh

Dow Tumbles 100 Points; Carnival Posts Upbeat Q3 Earnings

U.S. stocks were mixed; Dow and S&P 500 fell while Nasdaq edged up. Carnival beat estimates. BIO-Key surged 127%; oil dropped 2%.

Avi Kapoor

uniQure Filed for Huntington's Approval. Acceptance Is the Catalyst, Analyst Says

uniQure seeks accelerated FDA approval for its Huntington's gene therapy, AMT-130. William Blair resumes coverage with a $73 fair price.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-160.79M

Investing Cash Flow (TTM)

-262.97M

Financing Cash Flow (TTM)

584.35M

Free Cash Flow (TTM)

-161.45M

Capital Expenditure (TTM)

-665.00K

Net Change in Cash (TTM)

160.59M

Analyst Trends and Forecast

5

1

Jun

3

Jul

1

1

Sep

2

1

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$814.63M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

75.36

PB Ratio (TTM)

4.82

Earnings Yield % (TTM)

-18.03%

Earnings Yield % (FWD)

-9.90%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.67

Company Debt

Total Debt

$50.15M

LT Debt

$50.15M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$413.03M

Debt to Equity

0.19

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-